University of Toronto

The University of Toronto is a public research university located in Toronto, Ontario, Canada on the grounds that surround Queen's Park. It was founded by royal charter in 1827 as King's College, the first institution of higher learning in the colony of Upper Canada. Originally controlled by the Church of England, the university assumed the present name in 1850 upon becoming a secular institution.

Academically, the University of Toronto is noted for influential movements and curricula in literary criticism and communication theory, known collectively as the Toronto School. The university was the birthplace of insulin and stem cell research, and was the site of the first practical electron microscope, the development of multi-touch technology, the identification of the first black hole Cygnus X-1, and the development of the theory of NP-completeness.

Aatif Qureshi

B.HSc. (Hons), M.D. Candidate

Lead Research Analyst

Aatif is an MD candidate at the University of Toronto. He is motivated to be a physician leader dedicated to fostering compassionate and holistic care through his work in medical education, health systems leadership, and community engagement. He believes that education and mentorship are the central to creating lasting and impactful change in our world. He is also the Executive Co-Director of the student-run interprofessional IMAGINE clinic and outreach program that provides care to vulnerable and marginalized populations in the Greater Toronto Area. He believes BRIGHT to be an exemplar of the unifying force needed to bridge the gaps that limit health innovation. As a physician leader, he hopes to advocate for a collaborative network that allows stakeholders to work seamlessly to bring together technology, policy, and social values to make ‘health’ accessible to all.

Quinn Underwood

B.Sc. (Hons) Candidate

Lead Research Analyst

Quinn Underwood is a student at the University of Toronto studying Global Health and Immunology. He is active in various global health and entrepreneurial fields, and as founder of a health innovation consulting group looks to continue researching health science implementation and innovation scalability. A passionate advocate for student rights, he is also the founder of a company working to eliminate food-insecurity on campuses across Canada, and as part of his work on food-insecurity spent time in Myanmar research the possible application of mobile health technology to the diagnosis and treatment of child malnutrition.


Harbin Medical University

Harbin Medical University (HMU) is located in Harbin, a beautiful city well-known for its ice and snow and reputed as “Eastern Paris”. HMU has a scenic view on the campus dotted with ancient Chinese-style buildings, with a total area of 2.36 million square meters.

HMU was founded in 1926 and features a glorious history and tradition. It originated from the combination of former Harbin Medical University (its predecessor being Harbin Special Medical School founded by Dr. Wu Liande, a medical pioneer in China) and former 1st and 2nd branch schools of China Medical University in Xingshan (its predecessor being China Red Army Health School founded in Ruijin, Jiangxi, in 1931). During the last 80 years, HMU has inherited Dr. Wu Liande’s spirit of “loving the motherland wholeheartedly and succeeding by self-made efforts”, carried forward China Red Army Health School’s tradition of “firm political belief and excellent medical skills”, and upheld the motto: “integrity from the rules and learning to promote medicine”. HMU’s strength has been increasing leading it to become a medical school of huge capacity and distinct characteristics. HMU is one of the top medical schools in China and a national base for basic sciences research.

Yu-Jie Zhou

Ph.D. Candidate

Lead Research Analyst

The main focus of Zhou’s research is active natural products from bacteria. Recently, one of her research interests is the identification and characterization of intestinal bacteria that exhibit potent anti-malignancy activities on a broad range of tissues including a variety of solid tumor types and leukemia. She hopes to find new compounds which could help cancer patients conquer the disease with minimal side-effects.